Antitumor Activity and Safety of Pembrolizumab in Patients with Advanced Recurrent Ovarian Cancer: Results from the Phase 2 KEYNOTE-100 Study
Matulonis, U A, Shapira-Frommer, R, Santin, A D, Lisyanskaya, A S, Pignata, S, Vergote, I, Raspagliesi, F, Sonke, G S, Birrer, M, Provencher, D M, Sehouli, J, Colombo, N, González-Martín, A, Oaknin, AJournal:
Annals of Oncology
DOI:
10.1093/annonc/mdz135
Date:
May, 2019
File:
PDF, 847 KB
2019
File converter
More search results
More benefits 
